VF
TRIL

Virtu Financial’s Trillium Therapeutics Inc. TRIL Stock Holding History

Virtu Financial’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,232
Closed -$239K – 2358
2021
Q1 		$239K Buy
+22,232
New +$275K 0.02% 963
2020
Q3 		– Sell
-64,711
Closed -$524K – 1738
2020
Q2 		$524K Buy
+64,711
New +$400K 0.06% 359
2019
Q4 		$15K Sell
14,774
-20,217
-58% -$7.73K ﹤0.01% 1351
2019
Q3 		$11K Buy
34,991
+15,443
+79% +$5.22K ﹤0.01% 1345
2019
Q2 		$6K Buy
+19,548
New +$10.1K ﹤0.01% 1402
2019
Q1 		– Sell
-11,029
Closed -$19K – 2038
2018
Q4 		$19K Buy
+11,029
New +$33.1K ﹤0.01% 1381
2018
Q1 		– Sell
-19,898
Closed -$144K – 2864
2017
Q4 		$144K Buy
+19,898
New +$165K 0.01% 1802

Other funds holding TRIL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Virtu Financial's TRIL Position: Q2 2021 in Review

Virtu Financial sold out of Trillium Therapeutics Inc. (TRIL) in Q2 2021, closing a stake of 22,232 shares — an estimated $239K sold.

Virtu Financial first reported a position in TRIL in Q4 2017 and held it in 7 quarters. The position peaked at $524K in Q2 2020. 137 funds tracked by Wall St. Rank hold TRIL as of Q2 2021.

  • Virtu Financial reported no remaining Trillium Therapeutics Inc. position as of Q2 2021 after selling out during the quarter.
  • Virtu Financial sold 22,232 Trillium Therapeutics Inc. shares in Q2 2021, an estimated $239K.
  • Virtu Financial first reported a position in Trillium Therapeutics Inc. in Q4 2017 and held it in 7 quarters.
  • Virtu Financial's Trillium Therapeutics Inc. position peaked at $524K in Q2 2020.
  • 137 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2021.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.